ロード中...
Immunotherapy in Tumors: Activated T Cells as a New Treatment Modality
BACKGROUND: A number of new drugs for tumor immunotherapy have been approved in the past few years. They work by activating T cells to combat tumors. METHOD: This review is based on publications on recently approved T-cell-activating drugs that were retrieved by a selective search in PubMed. RESULTS...
保存先:
| 出版年: | Dtsch Arztebl Int |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Deutscher Arzte Verlag
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4709658/ https://ncbi.nlm.nih.gov/pubmed/26667979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2015.0809 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|